Creating Brighter Horizons for Patients
LumiThera is a global ophthalmic medical device company offering a comprehensive portfolio for detecting, treating, and monitoring retinal diseases, specifically dry age-related macular degeneration (AMD). Our mission is to provide light-based innovations that help preserve and improve patients’ quality of life.

Harnessing the Power of Light™
to Preserve and Improve Vision
LumiThera is developing products to improve visual function, slow or stop the progression of debilitating retinal diseases, and prevent vision loss. Through our commitment to innovation and rigorous clinical programs, LumiThera continues to push the boundaries of vision science.
Leading Photobiomodulation Innovation
LumiThera is the leader in ophthalmic photobiomodulation (PBM) with the Valeda® Light Delivery System. Valeda is the first and only FDA-authorized treatment for dry age-related macular degeneration (AMD) to improve vision. Valeda demonstrates improvements in clinical and anatomical outcomes, which support a disease-modifying benefit for patients with dry age-related macular degeneration (AMD). In addition to clinical benefits, Valeda has a proven and well-established safety profile.
